Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Jan. 19 to 22, 2021. This […]
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Jan. 19 to 22, 2021. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
Adults Delaying Even Emergency Care During COVID-19
FRIDAY, Jan. 22, 2021 (HealthDay News) — Two-thirds of Americans are concerned about going to medical appointments even for an emergency when COVID-19 rates are high in their area, according to the results of a survey released Jan. 12 by the Orlando Health Heart & Vascular Institute.
Antibody Drug May Protect Nursing Home Residents, Staff From COVID-19
FRIDAY, Jan. 22, 2021 (HealthDay News) — An antibody drug that has emergency use authorization from the U.S. Food and Drug Administration for use in early-stage COVID-19 patients with symptoms prevented COVID-19 infections in nursing residents and staff who were exposed to the virus, a new study shows.
Bamlanivimab + Etesevimab Reduces SARS-CoV-2 Viral Load
FRIDAY, Jan. 22, 2021 (HealthDay News) — Treatment with bamlanivimab and etesevimab, but not monotherapy with bamlanivimab, is associated with a reduction in severe acute respiratory syndrome coronavirus 2 viral load in patients with mild-to-moderate COVID-19, according to a study published online Jan. 21 in the Journal of the American Medical Association.
Cancer Screening, Diagnoses Down During Early Pandemic
FRIDAY, Jan. 22, 2021 (HealthDay News) — There was a significant decrease in the number of patients undergoing screening tests for cancer and in the number of resulting diagnoses of cancerous and precancerous lesions during the first peak of the COVID-19 pandemic, according to a research letter published online Jan. 14 in JAMA Oncology.
Tocilizumab Does Not Improve Outcomes in Severe COVID-19
THURSDAY, Jan. 21, 2021 (HealthDay News) — Tocilizumab plus standard care is not superior to standard care alone for improving clinical outcomes among patients with severe or critical COVID-19 and may increase mortality, according to a study published online Jan. 20 in The BMJ.
Mortality Decreased for COVID-19 ICU Patients Over Time
THURSDAY, Jan. 21, 2021 (HealthDay News) — For adults with COVID-19-related critical illness admitted to the intensive care unit, mortality has decreased over time, according to a study published online Jan. 19 in the Annals of Internal Medicine.
President Biden Unveils Details of National Pandemic Response Plan
THURSDAY, Jan. 21, 2021 (HealthDay News) — A day after his inauguration, President Joe Biden plans to unveil a new, far-reaching pandemic response plan. He will also issue executive orders that aim to ramp up the production and distribution of COVID-19 tests and vaccines, make schools and travel safer, and help states fight the spread of COVID-19.
Significant Association ID"d Between Hepatitis C, Overactive Bladder .jpg)
Study Looks at Barriers to Initiation of Rotavirus Vaccine 
~16 Percent of COVID Cases Develop Postacute Sequelae of SARS-CoV-2 
Obstructive Sleep Apnea Tied to Nearly Doubled Risk for Flu, COVID-19 in Childhood 
Adenotonsillectomy Tied to Increase in Respiratory Tract Infections in Children 
Physical Exams May Not Reliably Diagnose Pediatric Pneumonia .jpeg)
Flu Treatment With Oseltamivir Linked to Reduced Risk for Pediatric ICU Admissions, Length of Stay 
AAP Releases Influenza Vaccine Recommendations for All Children 6 Months and Older 
